Pincainide

This classification denotes an antiarrhythmic agent and anesthetic agent with the molecular formula C16H24N2O, a preparation that US FDA regulates as an active ingredient or moiety under Unique Ingredient Identifier (SRS UNII) 66803GMO3G, chemically known as 2,3,4,5,6,7-hexahydro-1h-azepine-1-aceto-2,6-xylidide but more generally known as pincainide, which bears US NIH Compound Identifier 71267. European Medicines Agency schedules Pincainide in its eXtended EudraVigilance Medicinal Product Dictionary or XEVMPD under Index SUB09853MIG. The term PINCAINIDE is an International Non-Proprietary Name or INN (see World Health Organization INN reference publication, Volume 37, No. 6, 1983, List 23). Most nations, for tariff and trade purposes, schedule pincainide under HS 29339930 and SITC 51577. As of Q4 2014, PINCAINIDE remains US FDA's Preferred Term for this commodity. Pincainide bears US NLM identifiers UMLS ID C0137074 and NCI Concept Code C66389. SMILES: O=C(NC1C(CCCC1C)C)CN1CCCCCC1.